Drugs / VELSECORAT
last change Jul 2020 re-read 2 minutes ago

VELSECORAT

also known as AZD7594

Other / unclassified targets NR3C1

Developed for
asthma
Investigated by
AstraZeneca · Parexel · Quotient Sciences

Trials 10 · a red edge is where a trial was stopped

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 18 trials
Phase 1 NCT04072562 Sep → Nov 2019 asthma AstraZeneca Completed No outcome recorded
Phase 1 NCT03976869 Jul 2019 → Jul 2020 asthma AstraZeneca Completed No outcome recorded
Phase 1 NCT04002427 Jun → Jul 2019 asthma AstraZeneca Completed No outcome recorded
Phase 1 NCT02928354 Nov 2016 → Mar 2017 AstraZeneca Completed No outcome recorded
Phase 1 NCT02967159 Nov 2016 → Apr 2017 asthma, chronic obstructive pulmonary disease AstraZeneca Completed No outcome recorded
Phase 1 NCT02645253 Jan → Apr 2016 asthma, chronic obstructive pulmonary disease AstraZeneca Completed No outcome recorded
Phase 1 NCT02648438 Jan → Jun 2016 asthma, chronic obstructive pulmonary disease AstraZeneca Completed No outcome recorded
Phase 1 NCT01636024 Sep 2012 → Jun 2013 AstraZeneca Completed No outcome recorded
Phase 22 trials
Phase 2 NCT03622112 Jan → Sep 2019 asthma AstraZeneca Completed No outcome recorded
Phase 2 NCT02479412 Jun 2015 → Feb 2016 asthma AstraZeneca Completed No outcome recorded

Evidence & citations 5 cited values

Every value below carries the sentence it was read from. 12 sources stand behind the page.

FieldValueCited text
Known as VELSECORAT ChEMBL registry synonym — accepted as the source's own label CHEMBL3666807
Known as AZD7594 AZD7594 is in clinical development for the treatment of asthma.” NCT04002427
9

NCT02645253

NCT01636024

NCT03976869

NCT02928354

NCT02479412

NCT02967159

NCT03622112

NCT02648438

NCT04072562

Modality Other / unclassified “AZD7594, an inhaled non-steroidal selective glucocorticoid receptor modulator” PMID 30777086 Feb 2019
Route Inhaled “Suspension inhaled via Spira nebuliser” NCT01636024
Target NR3C1 “Glucocorticoid receptor modulator” CHEMBL3666807